Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02238925
Brief Title: An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients

First Submitted : August 14, 2014
First Submitted that Met QC Criteria : September 11, 2014
First Posted : September 12, 2014 (Estimate)

Results First Submitted : September 3, 2017
Results First Submitted that Met QC Criteria : October 23, 2017
Results First Posted : November 30, 2017

Last Update Submitted that Met QC Criteria : October 23, 2017
Last Update Posted : November 30, 2017